Analgesics Market Size, Share, Opportunities, And Trends By Drug Type (Opioid, Non-opioid, Compound Medication), By Route of Administration (Oral, Parenteral, Transdermal, Others), By Application (Surgical and Trauma, Cancer, Neuropathic, Migraine, Pediatric, Others), By Distribution Channel (Offline, Online), And By Geography - Forecasts From 2023 To 2028

The analgesics market is estimated to grow at a CAGR of 6.21% during the forecast period.

Analgesics (painkillers) are medications used to alleviate or reduce pain. They are commonly used to manage various types of pain, ranging from mild to severe. The growing prevalence of chronic pain along with the increasing awareness about self-pain management is a major growth driver of the analgesics market. Moreover, the changing lifestyle and government support for research and clinical trials are further contemplated to propel the analgesics market.

Growing Prevalence of Chronic Pain

Chronic pain conditions such as arthritis, back pain, and neuropathic pain are prevalent worldwide. The aging population and the increasing incidence of chronic diseases are stimulating the analgesics market growth. For instance, CDC estimates that by 2040, approximately 78.4 million adults in the United States aged 18 years and older will be diagnosed with arthritis. This number represents around 25.9% of the expected total adult population at that time. In 2019, there were 18 million individuals worldwide who had rheumatoid arthritis, and approximately 55% of those living with rheumatoid arthritis were aged 55 years or older as per the WHO report.

Increased Pain Management Awareness

Increased awareness of pain management options and self-medication practices contribute to the steady demand for OTC analgesics. During the 2022 pain awareness month, the US Pain Foundation's #LifeWithPain initiative highlighted the terrible effects of chronic pain on people's lives. It was a month-long social media challenge that encouraged individuals to share their pain experiences and be aware of others. Moreover, IASP’s main theme for 2023 pain awareness month in September is the critical value of an individualized, multidisciplinary, and multimodal approach to pain management. Additionally, the #PainCounts initiative from ISAP urges people to share their pain care plan or strategy to promote multidisciplinary pain treatment.

Rapid Expansion of E-Commerce

The growing popularity of e-commerce platforms has made analgesics more accessible to consumers which are fuelling the analgesics market growth. For instance, e-commerce’s share of global retail sales increased from 14% in 2019 to about 17% in 2020 as per the UN Conference of Trade and Development (UNCTAD). Additionally, between August 2019 and August 2020, China's online market share of retail sales increased from 19.4% to 24.6% according to the same source.  Moreover, to hasten the digitization and digitalization of micro, small, and medium firms, Indonesia started a capacity-building initiative in 2020. Further, PE/VC capital for Indian e-commerce and consumer internet enterprises increased twice to US$ 15.4 billion in 2022 from US$ 8.2 billion in 2020 as per the NIP&FA data.

Government Initiatives and Health Reforms

Government initiatives aimed at improving healthcare infrastructure, access to medications, and patient awareness also play a role in driving the analgesics market. For instance, under the NIH HEAL Initiative in September 2022, the NIH provided grants and supplementary awards to aid clinical trials and clinical infrastructure. The initiative utilizes the National Center for Advancing Translational Sciences (NCATS) Trial Innovation Network's resources to facilitate clinical trials that assess the effectiveness of non-addictive pain treatments and both existing and novel pain prevention and management methods.

Lifestyle Changes and Work-Related Stress

Modern lifestyle factors, such as sedentary habits, long working hours, and increased stress, can lead to various types of pain, creating a demand for pain relief medications thereby propelling the analgesics market. For instance, highly sedentary service industries presently account for over 43% of all jobs in the US, and office workers spend more than 89% of their time sitting down as per the American Heart Association Research. Moreover, presently, the majority of adolescents, exceeding 80% and approximately 27% of adults fail to meet the physical activity guidelines set by the World Health Organization (WHO).

Restraints in the Market

The analgesics market has experienced growth and development however some restraints or challenges can impact its expansion. For example, opioid analgesics while effective in managing pain have been associated with a significant risk of abuse, addiction, and overdose. Moreover, the limited efficacy of existing analgesics in managing certain types of pain may lead to dissatisfaction among patients and healthcare providers thereby hindering market growth. Further, there has been an increased interest in non-pharmacological approaches to pain management such as physical therapy, cognitive-behavioral therapy, and alternative therapies like acupuncture. This shift in preferences can impact the demand for traditional analgesics.

North America is Expected to Grow Considerably

North America is expected to hold a significant share of the analgesics market during the forecast period. The factors attributed to such a share are a higher prevalence of chronic pain, chronic diseases, government support, increasing research and clinical trials, and increasing awareness. For instance, in 2019, around one-fifth (20.4%) of adults experienced chronic pain, while approximately 7.4% of adults had chronic pain that significantly impacted their daily life or work activities, referred to as high-impact chronic pain, within the previous three months. Moreover, the presence of major players such as Pfizer, and SingleCare further augments the analgesics market in the region through enhanced accessibility.

Major Market Players

• Farmson Pharmaceutical is a pharmaceutical company based in India. It is involved in the manufacturing and marketing of a wide range of pharmaceutical products including active pharmaceutical ingredients (APIs) and finished dosage formulations.
• The National Health Service (NHS) is the publicly funded healthcare system in the United Kingdom. The NHS Long Term Plan emphasizes personalized care as a fundamental commitment and one of its key components is supporting self-management to become a standard practice.
• SingleCare is a healthcare company based in the US that provides a free prescription savings card and a platform for accessing discounts on prescription medications, dental care, vision care, and telehealth services. It provides discounts on several analgesics including Cymbalta, Duloxetine Hcl, Elmiron, Pentosan, Fentora, and others.

Key Market Developments

• In December 2022, Lupin Ltd. based in India launched an authorized generic version of PENNSAID of Horizon Pharma Therapeutics in the US. PENNSAID is prescribed to treat inflammatory conditions such as gout and osteoarthritis, effectively alleviating pain in the knee and other joints.
• In August 2020, Arjuna Natural introduced Rhuleave-K, a unique botanical formula that has been clinically proven to provide safe pain relief with efficacy and speed comparable to well-known over-the-counter drugs like acetaminophen (paracetamol).

Analgesics Market Scope:

 

Report Metric	Details
Growth Rate	CAGR of 6.21% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Drug Type, Route of Administration, Application, Distribution Channel, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Sonika Life Sciences, Farmson Pharmaceutical, Bupa, Pacific India, NHS, Pfizer, SingleCare, Physio-pedia, Tylenol, Mayo Clinic
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Drug Type
  • Opioid
  • Non-opioid
  • Compound Medication
• By Route of Administration
  • Oral
  • Parenteral
  • Transdermal
  • Others
• By Application
  • Surgical and Trauma
  • Cancer
  • Neuropathic
  • Migraine
  • Pediatric
  • Others
• By Distribution Channel
  • Offline
  • Online
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. ANALGESICS MARKET, BY DRUG TYPE

5.1. Introduction

5.2. Opioid 

5.3. Non-opioid

5.4. Compound Medication

6. ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION

6.1. Introduction

6.2. Oral

6.3. Parenteral

6.4. Transdermal

6.5. Others

7. ANALGESICS MARKET, BY APPLICATION

7.1. Introduction

7.2. Surgical and Trauma

7.3. Cancer

7.4. Neuropathic

7.5. Migraine

7.6. Pediatric

7.7. Others

8. ANALGESICS MARKET, BY DISTRIBUTION CHANNEL

8.1. Introduction

8.2. Offline

8.3. Online

9. ANALGESICS MARKET, BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Spain

9.4.5. Others

9.5. The Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. Japan

9.6.2. China

9.6.3. India

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

11.1. Sonika Life Sciences

11.2. Farmson Pharmaceutical

11.3. Bupa

11.4. Pacific India

11.5. NHS

11.6. Pfizer

11.7. SingleCare

11.8. Physio-pedia

11.9. Tylenol

11.10. Mayo Clinic

Sonika Life Sciences

Farmson Pharmaceutical

Bupa

Pacific India

NHS

Pfizer

SingleCare

Physio-pedia

Tylenol

Mayo Clinic